If you're speaking of shipments of products for sa
Post# of 15624
(Total Views: 383)
Posted On: 08/31/2017 1:55:53 PM
If you're speaking of shipments of products for sale, while I believe that Emilia has the capability of making the product to ship, the company's insistence on selling drugs, not cosmetics, extends the point at which they'll be selling the product to at least the point they're convinced it's a viable drug.
If the expansion of the Phase 1 trial treats sufficient numbers of patients with psoriasis and other skin disorders to truly claim efficacy, that could be the point at which they're willing to let Mediq, and perhaps others, sell the drug. It's possible that could be by fourth quarter of the year.
On the other hand, if they were looking to gain approval of a Govt. based on trial results, I believe they'd need far more than a small efficacy trial to do so, but it certainly could be far faster elsewhere than in the U.S. While I certainly like the idea that our products could be covered by Insurance because they had Govt. approval, as I understand it, if efficacy is proven, insurance companies can be forced to pay for products even without Govt. approval. Here in the U.S. I believe in a few cases courts have ruled that certain cannabis products had to be paid for by the insurance company when they were the only product known to give the patient relief.
I would hope that OWCP falls into the area where at least some of the products they intend to market show demonstrated efficacy in trials, but aren't carried to the point of Govt. approval before they're on the market. If that's the case, it could happen in 2 to 6 months, but it could be years for Govt. approval, especially if we're speaking of the U.S. Govt. and FDA approval. We really need the Govt. here to recognize the medical benefits of cannabis and quite threatening the industry.
Gary
If the expansion of the Phase 1 trial treats sufficient numbers of patients with psoriasis and other skin disorders to truly claim efficacy, that could be the point at which they're willing to let Mediq, and perhaps others, sell the drug. It's possible that could be by fourth quarter of the year.
On the other hand, if they were looking to gain approval of a Govt. based on trial results, I believe they'd need far more than a small efficacy trial to do so, but it certainly could be far faster elsewhere than in the U.S. While I certainly like the idea that our products could be covered by Insurance because they had Govt. approval, as I understand it, if efficacy is proven, insurance companies can be forced to pay for products even without Govt. approval. Here in the U.S. I believe in a few cases courts have ruled that certain cannabis products had to be paid for by the insurance company when they were the only product known to give the patient relief.
I would hope that OWCP falls into the area where at least some of the products they intend to market show demonstrated efficacy in trials, but aren't carried to the point of Govt. approval before they're on the market. If that's the case, it could happen in 2 to 6 months, but it could be years for Govt. approval, especially if we're speaking of the U.S. Govt. and FDA approval. We really need the Govt. here to recognize the medical benefits of cannabis and quite threatening the industry.
Gary
(0)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼